Suono Bio announced today that it raised $8.5 million for its drug delivery platform in an oversubscribed Series A financing round. Foxborough, Mass.-based Suono Bio had its financing led by Axil Capital and Mizuho Securities Principal Investment. Taiwanaia Capital and other investors also participated. According to a news release, Suono Bio will use the funds […]
suonobio
Fujifilm backs therapeutic administration dev Suono Bio
Suono Bio said today that Fujifilm (TSE:4901) made an undisclosed investment in the company to support its next-gen technology intended for the rapid, formulation-independent administration of therapeutics. The Cambridge, Mass.-based company, formed last year by researchers out of the Massachusetts Institute of Technology and Brigham & Women’s Hospital, is developing technology intended for the rapid local administration of […]
